Menu
Back to User profile » Dr Koichiro Tatsumi
Papers published by Dr Koichiro Tatsumi:
Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients
Suzuki E, Kawata N, Shimada A, Sato H, Anazawa R, Suzuki M, Shiko Y, Yamamoto M, Ikari J, Tatsumi K, Suzuki T
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1077-1090
Published Date: 7 June 2023
Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel
Yoshioka K, Abe M, Shiko Y, Koshikawa K, Kawasaki Y, Iwasawa S, Terada J, Tsushima K, Tatsumi K, Suzuki T
Drug Design, Development and Therapy 2022, 16:759-767
Published Date: 22 March 2022
Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis
Sakayori M, Terada J, Abe M, Hirasawa Y, Suzuki K, Yoshioka K, Tsushima K, Tatsumi K
Drug Design, Development and Therapy 2019, 13:2295-2303
Published Date: 11 July 2019
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter]
Abe M, Tsushima K, Tatsumi K
Drug Design, Development and Therapy 2019, 13:1687-1688
Published Date: 14 May 2019
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Corrigendum]
Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K
Drug Design, Development and Therapy 2019, 13:807-808
Published Date: 28 February 2019
Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience
Matsumura T, Terada J, Yoshimura C, Koshikawa K, Kinoshita T, Yahaba M, Nagashima K, Sakao S, Tatsumi K
Drug Design, Development and Therapy 2019, 13:809-816
Published Date: 28 February 2019
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K
Drug Design, Development and Therapy 2018, 12:3369-3375
Published Date: 9 October 2018
Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression?
Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:551-560
Published Date: 13 February 2017
Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
Fukuchi Y, Tatsumi K, Inoue H, Sakata Y, Shibata K, Miyagishi H, Marukawa Y, Ichinose M
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:831-838
Published Date: 21 April 2016
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study
Abe M, Tsushima K, Matsumura T, Ishiwata T, Ichimura Y, Ikari J, Terada J, Tada Y, Sakao S, Tanabe N, Tatsumi K
Drug Design, Development and Therapy 2015, 9:5755-5762
Published Date: 23 October 2015
Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document
Suzuki T, Tada Y, Kawata N, Ikari J, Kasahara Y, Sakurai Y, Iesato K, Nishimura R, West J, Tatsumi K
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1199-1205
Published Date: 19 June 2015
Clinical, physiological, and radiological features of asthma–chronic obstructive pulmonary disease overlap syndrome
Suzuki T, Tada Y, Kawata N, Matsuura Y, Ikari J, Kasahara Y, Tatsumi K
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:947-954
Published Date: 15 May 2015